Suzuken Co., Ltd. (TYO:9987)

Market Cap	405.83B +16.0%
Revenue (ttm)	2.45T +1.5%
Net Income	34.84B +1.9%
EPS	490.34 +10.7%
Shares Out	67.64M
PE Ratio	12.24
Forward PE	13.72
Dividend	100.00 (1.67%)
Ex-Dividend Date	Mar 30, 2026

Volume	314,800
Average Volume	226,750
Open	6,000.00
Previous Close	5,950.00
Day's Range	5,957.00 - 6,002.00
52-Week Range	4,406.00 - 6,668.00
Beta	0.15
RSI	45.48
Earnings Date	May 13, 2026

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplie...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 12,923
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In fiscal year 2025, Suzuken's revenue was 2.40 trillion, an increase of 0.56% compared to the previous year's 2.39 trillion. Earnings were 34.50 billion, an increase of 18.89%.